Literature DB >> 19047965

Prader Willi Syndrome: saliva quantification and culture in 10 patients.

Laila Cuba González1, Cristina García Villa, Abel Cahuana Cárdenas.   

Abstract

Prader Willi Syndrome (PWS) is a relatively rare neurogenetic illness. It is of interest to dentists for its clinical characteristics. The aim of this study was to evaluate the amount of saliva and the presence of Streptococcus mutans (St mutans) in patients with this syndrome. We measured saliva stimulated by chewing paraffin tablets for 5 minutes, and cultured saliva samples in order to determine the colony-forming units (CFUs) of St mutans. The study was conducted in a group of 10 children with PWS at the Hospital Sant Joan de Déu, Barcelona. Results showed that patients with PWS had lower saliva secretion than considered normal for a standard population and most cultures presented a high number of colony-forming units. We conclude that these patients are likely to present caries, and stress the need to place special emphasis on prevention.

Entities:  

Mesh:

Year:  2008        PMID: 19047965

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


  3 in total

1.  An investigation into the dental health of children with obesity: an analysis of dental erosion and caries status.

Authors:  H J Tong; M C J Rudolf; T Muyombwe; M S Duggal; R Balmer
Journal:  Eur Arch Paediatr Dent       Date:  2013-12-06

2.  Special Care Dentistry in a Patient with Prader-Willi Syndrome through the Use of Atraumatic Restorative Treatment under General Anesthesia.

Authors:  Caio Vinícius Gonçalves Roman-Torres; Sérgio Takashi Kussaba; Yasmin Comoti Vita Bantim; Roberta de Barros Antunes Almeida de Oliveira
Journal:  Case Rep Dent       Date:  2017-11-28

3.  Oral disorders in children with Prader-Willi syndrome: a case control study.

Authors:  Carla Munné-Miralvés; Lluís Brunet-Llobet; Abel Cahuana-Cárdenas; Sergi Torné-Durán; Jaume Miranda-Rius; Alejandro Rivera-Baró
Journal:  Orphanet J Rare Dis       Date:  2020-02-10       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.